Skip to main content
. 2015 May 3;2015:687196. doi: 10.1155/2015/687196

Table 1.

Structure of the experiment.

Groups n Drug treatment Agents administrated to induce inflammation
Group I Normal control 10
Group II Chronic prostatitis 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.)
Group III Oligonol 9 Oligonol 60 mg/kg (p.o.) 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.)
Group IV Acupuncture 7 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.)
Group V Quantum 7 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.)
Group VI Oligonol + quantum 8 Oligonol 60 mg/kg (p.o.) 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.)
Group VII Acupuncture + oligonol 9 Oligonol 60 mg/kg (p.o.) 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.)
Group VIII Quantum + acupuncture 8 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.)
Group IX Quantum + oligonol + acupuncture 9 Oligonol 60 mg/kg (p.o.) 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.)

E2, 17-beta-estradiol; DHT, dihydrotestosterone; s.c., subcutaneous injection; p.o., oral administration.